Thu, Dec 25, 2014, 2:42 AM EST - U.S. Markets closed for Christmas


% | $
Quotes you view appear here for quick access.

Biodel Inc. (BIOD) Message Board

you are viewing a single comment's thread.

view the rest of the posts
  • stvwingert stvwingert Sep 28, 2011 8:54 AM Flag

    The Business of Diabetes: Biodel Linjeta Update

    The article/blog as a whole seems very well researched.

    The one thing I think he has wrong, though, is his prediction of a possible Linjeta NDA application in early 2012. My understanding is they need to run 2 more phase 3 trials first before Linjeta can be approved.

    still, the value of the technology and research to another major drug co. with patents expiring certainly makes sense. So BIOD could definitely be a takeover candidate. Especially when a potential acquirer could be accumulating shares of BIOD at well under cash per share!

    SortNewest  |  Oldest  |  Most Replied Expand all replies
1.36-0.04(-2.86%)Dec 24 1:00 PMEST

Trending Tickers

Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.